azacitidine 200 mg tablet, azacitidine 150 mg tablet, azacitidine 300 mg tablet, azacitidine 100 mg tablet clinical trials

Phase 2, open-label, single-arm rollover study to evaluate long-term Safety in subjects who participated in other Celgene sponsored CC-486 (oral Azacitidine) clinical trials in Hematological disorders

This study is looking at the long-term safety of a tablet called azacitidine (also known as CC-486) for people with blood disorders. It's for those who have already taken part in other studies with this medicine, to keep an eye on any side effects over time.